Pharma and NHS working in partnership for older patients

Pharma and NHS working in partnership

A partnership to improve outcomes for malnourished older patients has had a positive impact on this vulnerable and often marginalised group. The challenges Tackling the crisis There...
Illustration of people meeting at a table that looks like a pill: meeting customer needs

The three stage plan for meeting customer needs

Taking a fresh look at NHS engagement is where success in meeting customers’ needs lies. But how? David Southern explores.  Existing commercial models of UK...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Mark Toms profile: Article on joint-working

Building a healthier future for our NHS through joint working

In a resource-scarce and budget-strained environment, Joint Working Projects between the NHS and the pharmaceutical industry are helping to meet the healthcare challenges of...
SMC accepts letermovir for use within NHS Scotland for appropriate patients.

Achieving value in the NHS through partnership

How AbbVie’s ‘Decisions with Value’ initiative brought healthcare experts together to tackle the challenge of improving health outcomes while making savings. Over recent years the NHS...
The Topol Review and innovative technologies in the NHS

Advancing electronic prescribing

The Electronic Prescription Service (EPS) sends electronic prescriptions from GP surgeries to pharmacies and currently accounts for around 64% of all prescriptions issued in...
Chris Molloy from Medicines Discovery Catapult

Medicines Discovery Catapult and the high impact medicines discovery

Chris Molloy is the Chief Executive Officer of the Medicines Discovery Catapult (MDC). He joined the organisation two years ago as only the second...
Lucy Jones - Doctors of the World

Doctors of the World: Healthcare for everyone

Lucy Jones, Director of Programmes at Doctors of the World UK, supports access to healthcare for excluded people around the world. She joined the...
Lynda Bailey and Sarah Davies on managing the menopause at work

Managing the menopause at work

Every woman will go through the menopause, so why is it rarely discussed openly in a work environment? A significant cultural shift is required in...
Dmitry Schourov on uniting traditional and digital marketing

Uniting traditional and digital marketing

Dmitry Schourov is Strategy and Commercial Operations Director at Pfizer Russia, responsible for full strategic support of the business and all operational support including...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...